Co-Diagnostics Abandons Annual Meeting After Fourth Quorum Failure; Reverse-Split Vote Punted to Special Meeting
CODX is trading near its 52-week low of $0.711 (1.4% above the low).
Summary
Co-Diagnostics abandoned its Annual Meeting after a fourth failed quorum attempt and will seek the reverse-split and warrant-exercise approvals at a future special meeting instead.
Key Events · Corporate Governance and Compliance · CODX
-
Annual Meeting Abandoned After Fourth Quorum Failure
The October 14, 2026 reconvened Annual Meeting again lacked a quorum, and the company determined not to adjourn again — ending the meeting without transacting any business.
-
Reverse-Split Vote Punted to Special Meeting
The company intends to seek approval of the Annual Meeting proposals — including a reverse stock split of up to 1-for-50 and the exercise of 3.4 million warrants, per the September 21 PRE 14A — at a future special meeting on a date not yet announced.
-
Governance Risk From Repeated Quorum Failures
Four consecutive sessions (September 3, September 24, September 30, October 14) failed to reach quorum, raising the risk the special meeting fails the same way and further delays the reverse split.
-
Distress Backdrop
The company carries a going-concern warning, $3.6M of cash, a $15.4M six-month net loss, and a $2.1M convertible loan with a 35% OID that cedes all ATM proceeds to the lender, as previously disclosed.
Analysis · CODX · Industrial Applications And Services
Four times now, Co-Diagnostics has failed to get enough shareholders to show up: the September 3 Annual Meeting, two adjourned sessions on September 24 and September 30, and a final reconvening on October 14 — all without a quorum. The company has given up on the Annual Meeting entirely and will instead call a special meeting to seek approval of the proposals that were on that agenda, which per the September 21 proxy include a reverse stock split of up to 1-for-50 and the exercise of 3.4 million warrants. That matters because the company is trading near its 52-week low of $0.71 with a going-concern warning, $3.6M of cash, and a $2.1M convertible loan with a 35% OID that cedes all ATM proceeds to the lender — a reverse split is the likely path to regaining Nasdaq compliance, and every delay keeps that fix on hold. The repeated inability to reach quorum also raises the practical risk that the special meeting fails the same way, further delaying the split and the warrant exercise.
How filings like this one have moved
In the 30 days to Oct 15, 2026, 28.9% of the 1476 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.47%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CODX was trading at $0.72 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $5.3M. The 52-week trading range was $0.71 to $46.50. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.